Deborah Knobelman

Chief Financial Officer, Senti Biosciences Holdings, Inc.

Companies

Kronos Bio, Inc.Chief executive officer Jun 6, 2025 to now¹
Kronos Bio, Inc.President Jun 6, 2025 to now¹
Kronos Bio, Inc.Chief financial officer Jun 4, 2024 to now²
Senti Biosciences Holdings, Inc.Chief financial officer Jun 15, 2022 to Feb 2, 2024³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Senti Biosciences Holdings, Inc. SNTI131,000 shares⁴$29.1K at $0.22Feb 1, 2024
Kronos Bio, Inc.0 shares⁵Jun 20, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 20, 2025U 139,422 shares at $0.57 of Kronos Bio, Inc.⁵
Jun 5, 2025Sold 24,838 shares at $0.87 of Kronos Bio, Inc.⁶
Jun 3, 2024Granted 164,260 shares of Kronos Bio, Inc.⁷
Feb 1, 2024Granted 101,000 shares of Senti Biosciences Holdings, Inc.⁴
Oct 3, 2022Granted 30,000 shares of Senti Biosciences Holdings, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKronos Bio, Inc., Chief executive officer
2
SEC EDGARKronos Bio, Inc., Chief financial officer
3
SEC EDGARSenti Biosciences Holdings, Inc., Chief financial officer
4
SEC EDGARSenti Biosciences Holdings, Inc. shares after the filing of Feb 1, 2024
5
SEC EDGARKronos Bio, Inc. shares after the filing of Jun 20, 2025
6
SEC EDGARForm 4 filed Jun 6, 2025
7
SEC EDGARForm 4 filed Jun 4, 2024
8
SEC EDGARForm 4 filed Oct 4, 2022